Table 3.
Relevant miRNA in oxidative stress.
miRNAs | Tissue/organ/cell line | Source | Target | Functions | Reference |
---|---|---|---|---|---|
NHMC | Human | SOD1/2, PAK1 | Fibronectin synthesis | [58] | |
miR-377 | MES 13 mesangial cells | Mouse | |||
Kidney | Mouse | ||||
| |||||
miR-23a~27a~24-2 | HEK293T | Human | ER stress and UPR pathways-associated apoptosis | [60] | |
| |||||
miR-23b | Renal epithelial cells, podocyte | Mice, Rat | TGF-β receptor type II, SMAD3, TGF-β1 | Negative feedback loop-regulating TGF-β1 signaling | [61] |
| |||||
miR-335 | Kidney, primary mesangial cells | Rat | SOD2 | Renal aging | [64] |
miR-34a | Txnrd2 | ||||
| |||||
miR-24 miR-34a |
Kidney, CRL 2573 mesangial cell | Rat | UCP2 | Oxidative stress damage | [67] |
| |||||
miR-205 | HK-2 renal tubular cell | Human | PHD1/EGLN2 | Antioxidative and anti-ER stress | [69] |
| |||||
miR-200c | HUVEC | Human | ZEB1 | Cell growth arrest, apoptosis, and cellular senescence | [70] |
| |||||
miR-200a/-141 | Fibroblasts, | Mice | p38α | Enhanced oxidative stress, tumorigenesis, and chemosensitivity | [71] |
CT26 colon carcinoma, | Mice | ||||
NMuMG mammary gland epithelial cells, | Mice | ||||
MDA-MB-435S melanoma cells, | Human | ||||
293T kidney cells, | Human | ||||
MDA-MB-436 and BT-549 breast adenocarcinoma, | Human | ||||
SKOV3 ovarian adenocarcinoma | Human | ||||
| |||||
miR-200c/-141 | Heart | Mice | Slc25a3 | Decreased mitochondrial ATP production | [72] |
HEK293 | Human | ||||
| |||||
miR-21 | VSMCs | Rat | PDCD4 | Cellular injury | [73] |
| |||||
miR-21 | HUVECs | Human | PTEN | Increased NO production, reduced apoptosis | [74] |
| |||||
miR-21 | Angiogenic progenitor cell | Human | SOD2 | Increased intracellular ROS concentration and impaired NO bioavailability | [75] |
| |||||
miR-210 | Kidney | Mice | Activation of VEGF Signaling pathway | [76] | |
HUVECs | Human |
ATP: adenosine-triphosphate; ER: endoplasmic reticulum; HEK: human embryonic kidney cells; HUVECs: human umbilical vein endothelial cells; NF-kB: nuclear factor k-light-chain-enhancer of activated B cells; NHMC: normal human mesangial cells; NO: nitric oxide; PAK1: P21 protein (Cdc42/Rac)-activated kinase 1; PDCD4: programmed cell death 4; PHD1/EGLN2: prolyl hydroxylase 1; PTEN: phosphatase and tensin homolog; ROS: reactive oxygen; Slc25a3: solute carrier family 25 member 3; SOD: superoxide dismutase; TGF-β: transforming growth factor-β; Txnrd2: thioredoxin reductase 2; UCP2: uncoupling protein 2; UPR: unfolded protein response; VEGF: vascular endothelial growth factor; VEGF: vascular endothelial growth factor; ZEB1: zinc finger E-box-binding homeobox 1.